. Author manuscript; available in PMC: 2019 Apr 1.

Published in final edited form as: Acta Radiol. 2017 Jul 26;59(4):478–484. doi: 10.1177/0284185117723370

Table 1. Patient characteristics.

Data presented as mean ± SD for continuous variables and n (%) for categorical variables

	n =60
Females	28 (46.7)
Males	32 (53.3)
Age at PET/CT (years)	50±18
BMI at PET/CT	27.4 ± 6.0
Sarcoma type adipocytic fibroblastic smooth-muscle skeletal muscle uncertain diff. chondrogenic vascular	9 (15.0) 14 (23.3) 5 (8.3) 3 (5.0) 26 (43.3) 2 (3.3) 1 (1.7)
Sarcoma stage 1 2 3 4	6 (10.0) 29 (48.3) 20 (33.3) 5 (8.3)
Sarcoma grade 1 2 3	7 (11.7) 39 (65.0) 14 (23.3)
Sarcoma size (cm)	7.7 ± 6.5
Comorbidities none cardiovascular (CV) diabetes mellitus (DM) CV + DM	31 (51.7) 24 (40.0) 2 (3.3) 3 (5.0)
Therapy Pre-operative radiation Post-operative radiation Pre-operative radiation dose (Gy) Post-operative radiation dose (Gy) Adjuvant chemotherapy	60 (100) 20 (33.3) 46.3±11.6 40.9±18.5 13 (22.0)
Positive resection margins	19 (32.8)